Acadian Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-9,351
Closed -$519K – 2119
2025
Q3
$519K Buy
+9,351
New +$501K ﹤0.01% 1206
2024
Q4
– Sell
-2,099
Closed -$167K – 2152
2024
Q3
$167K Buy
2,099
+423
+25% +$31.8K ﹤0.01% 1425
2024
Q2
$120K Buy
+1,676
New +$123K ﹤0.01% 1509
2022
Q4
– Sell
-9,924
Closed -$701K – 1915
2022
Q3
$701K Sell
9,924
-5,368
-35% -$464K ﹤0.01% 898
2022
Q2
$1.32M Buy
+15,292
New +$1.43M 0.01% 750
2022
Q1
– Sell
-3,628
Closed -$469K – 1799
2021
Q4
$469K Hold
3,628
– – ﹤0.01% 1027
2021
Q3
$439K Hold
3,628
– – ﹤0.01% 1085
2021
Q2
$408K Sell
3,628
-848
-19% -$89.3K ﹤0.01% 1211
2021
Q1
$427K Buy
4,476
+516
+13% +$47.1K ﹤0.01% 1256
2020
Q4
$314K Hold
3,960
– – ﹤0.01% 1388
2020
Q3
$245K Buy
+3,960
New +$258K ﹤0.01% 1378
2020
Q2
– Sell
-2,032
Closed -$96K – 2338
2020
Q1
$96K Buy
+2,032
New +$102K ﹤0.01% 1359
2019
Q3
– Sell
-140
Closed -$7K – 2003
2019
Q2
$7K Buy
+140
New +$7.05K ﹤0.01% 1672
2018
Q3
– Sell
-28
Closed -$1K – 1790
2018
Q2
$1K Buy
+28
New +$1.07K ﹤0.01% 1666
2016
Q4
– Sell
-97,140
Closed -$2.66M – 1765
2016
Q3
$2.66M Sell
97,140
-127,896
-57% -$3.51M 0.01% 478
2016
Q2
$6.34M Buy
+225,036
New +$5.78M 0.03% 321
2016
Q1
– Sell
-5,628
Closed -$127K – 1489
2015
Q4
$127K Buy
+5,628
New +$128K ﹤0.01% 1031
2015
Q1
– Sell
-29,196
Closed -$674K – 1458
2014
Q4
$674K Buy
29,196
+16,724
+134% +$383K ﹤0.01% 718
2014
Q3
$292K Buy
+12,472
New +$292K ﹤0.01% 731

Other funds holding TECH

Acadian Asset Management's TECH Position: Q4 2025 in Review

Acadian Asset Management sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 9,351 shares — an estimated $519K sold.

Acadian Asset Management first reported a position in TECH in Q3 2014 and held it in 19 quarters. The position peaked at $6.34M in Q2 2016. 586 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Acadian Asset Management reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • Acadian Asset Management sold 9,351 Bio-Techne shares in Q4 2025, an estimated $519K.
  • Acadian Asset Management first reported a position in Bio-Techne in Q3 2014 and held it in 19 quarters.
  • Acadian Asset Management's Bio-Techne position peaked at $6.34M in Q2 2016.
  • 586 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Acadian Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.